Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...

The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are ...

Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N) said on Wednesday it was withdrawing its sickle cell disease treatment ...

We recently published a list of 7 Best Low Cost Stocks To Buy Under $50. In this article, we are going to take a look at ...